289 related articles for article (PubMed ID: 22422501)
1. Levels of plasma-soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) are correlated with disease activity in rheumatoid arthritis.
Choi ST; Kang EJ; Ha YJ; Song JS
J Rheumatol; 2012 May; 39(5):933-8. PubMed ID: 22422501
[TBL] [Abstract][Full Text] [Related]
2. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis.
Chen CH; Liao HT; Chen HA; Liang TH; Wang CT; Chou CT
J Rheumatol; 2008 Sep; 35(9):1846-8. PubMed ID: 18634145
[TBL] [Abstract][Full Text] [Related]
3. Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease.
Billioud V; Gibot S; Massin F; Oussalah A; Chevaux JB; Williet N; Bronowicki JP; Bigard MA; Guéant JL; Peyrin-Biroulet L
Dig Liver Dis; 2012 Jun; 44(6):466-70. PubMed ID: 22341488
[TBL] [Abstract][Full Text] [Related]
4. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
5. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
[TBL] [Abstract][Full Text] [Related]
6. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.
Valle Y; Ledezma-Lozano IY; Torres-Carrillo N; Padilla-Gutiérrez JR; Navarro-Hernández RE; Vázquez-Del Mercado M; Palafox-Sánchez CA; Armendáriz-Borunda J; Muñoz-Valle JF
Scand J Rheumatol; 2009; 38(5):332-5. PubMed ID: 19579138
[TBL] [Abstract][Full Text] [Related]
7. Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis.
Collins CE; La DT; Yang HT; Massin F; Gibot S; Faure G; Stohl W
Ann Rheum Dis; 2009 Nov; 68(11):1768-74. PubMed ID: 19054829
[TBL] [Abstract][Full Text] [Related]
8. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis.
Yasuda T; Takeyama Y; Ueda T; Shinzeki M; Sawa H; Takahiro N; Kamei K; Ku Y; Kuroda Y; Ohyanagi H
Crit Care Med; 2008 Jul; 36(7):2048-53. PubMed ID: 18552693
[TBL] [Abstract][Full Text] [Related]
10. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
13. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.
Park JJ; Cheon JH; Kim BY; Kim DH; Kim ES; Kim TI; Lee KR; Kim WH
Dig Dis Sci; 2009 Jul; 54(7):1525-31. PubMed ID: 18975078
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
15. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.
Yildirim K; Karatay S; Melikoglu MA; Gureser G; Ugur M; Senel K
Ann Clin Lab Sci; 2004; 34(4):423-6. PubMed ID: 15648784
[TBL] [Abstract][Full Text] [Related]
16. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis.
Barati M; Bashar FR; Shahrami R; Zadeh MH; Taher MT; Nojomi M
J Crit Care; 2010 Jun; 25(2):362.e1-6. PubMed ID: 19914031
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-cleaved osteopontin is increased in urine of patients with rheumatoid arthritis.
Shio K; Kobayashi H; Asano T; Saito R; Iwadate H; Watanabe H; Sakuma H; Segawa T; Maeda M; Ohira H
J Rheumatol; 2010 Apr; 37(4):704-10. PubMed ID: 20156944
[TBL] [Abstract][Full Text] [Related]
18. sTREM-1 in patients with chronic kidney disease on hemodialysis.
Essa ES; Elzorkany KM
APMIS; 2015 Nov; 123(11):969-74. PubMed ID: 26495896
[TBL] [Abstract][Full Text] [Related]
19. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
[TBL] [Abstract][Full Text] [Related]
20. Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis.
Molad Y; Ofer-Shiber S; Pokroy-Shapira E; Oren S; Shay-Aharoni H; Babai I
Eur J Clin Invest; 2015 Jun; 45(6):557-64. PubMed ID: 25832796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
